RU58841
| 제품명 | RU58841 |
|---|---|
| CAS 번호 | 154992-24-2 |
| 다른 이름 | PSK-3841; RU 58841; 4-(4,4-Dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile |
| 분자식 | C13H10F3N3O2 |
| 분자량 | 297.23 g/mol |
| 외관 | 흰색에서 미백색의 결정성 분말 |
| 분석법 (HPLC) | ≥98.0% |
| 건조 손실 | ≤0.5% |
| 중금속 | ≤10 ppm |
| 용해도 | Soluble in DMSO, ethanol; slightly soluble in water |
| 패키지 | 1 kg, 5 kg, 25 kg drums |
도움이 필요하신가요? 저희 팀에 문의해 주세요

동의어: PSK-3841, RU 58841, 4-(4,4-Dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile, RU-58841, 154992-24-2
RU58841 is a non-steroidal anti-androgen that has carved a niche in the research community for its topical activity against androgenetic alopecia and androgen-related skin conditions. Developed initially by Roussel Uclaf, this compound is a derivative of the topical anti-androgen flutamide, engineered to exert local effects without significant systemic absorption. It is available as a high-purity powder, typically ≥98% by HPLC, making it suitable for formulation and preclinical studies.
In the B2B arena, RU58841 is sought after by pharmaceutical and cosmetic ingredient buyers for its potential in hair care and dermatological products. Its mechanism involves competitive binding to the androgen receptor, thereby blocking dihydrotestosterone (DHT) from triggering follicle miniaturization. While not yet approved for clinical use, its profile continues to attract interest in the development of next-generation anti-hair loss solutions.
| 매개변수 | 사양 |
|---|---|
| 외관 | 흰색에서 미백색의 결정성 분말 |
| 분석법 (HPLC) | ≥98.0% |
| 건조 손실 | ≤0.5% |
| 중금속 | ≤10 ppm |
| 용해도 | Soluble in DMSO, ethanol; slightly soluble in water |
| 입자 크기 | NLT 98% through 80 mesh |